Skip to Main Content

Paper Details

Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury.
Sci Rep
0
2022
Author NameAffiliation
Iwan C C van der HorstMaastricht University Medical Center+
Iwan C C van der HorstCardiovascular Research Institute Maastricht (CARIM), Maastricht University
  • 1 - 2

Datasets

Release 1.2